14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
×
Home
/
Stock Analysis
/
Compare Terminal
/
BDMDW vs ASPSZ
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
BDMDW vs ASPSZ: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
BDMDW Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 1–2 Matrix Metrics)
BDMDW Overall Winner
6-Pillar Tally: BDMDW 0 – 0 ASPSZ (6 Tie)
Matrix Metrics: BDMDW 1 – 2 ASPSZ
As of Nov 20, 2026, Baird Medical Investment Holdings Ltd Warrant (BDMDW) is the stronger overall head-to-head candidate over Altisource Portfolio Solutions S.A. Cash Exercise Stakeholder Warrants (ASPSZ) in the Tradestie Institutional Equity Comparison Engine, winning 1–2 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). BDMDW carries a Unified Composite Score of 48.8/100 (HOLD) at $0.02 (N/M Forward P/E, N/A operating margin), whereas ASPSZ carries 47.1/100 (HOLD) at $0.18 (N/M Forward P/E, N/A operating margin).
BDMDW
NASDAQ
Head-to-Head Winner
Baird Medical Investment Holdings Ltd Warrant
Institutional Equity
Market Cap
N/A
TTM Revenue
N/A
Forward P/E
N/M
Beta / 30D Vol
-0.19β · 641% Vol
Unified Composite Score
48.8 / 100
HOLD
Tech 50.0
Fund 50.0
Flow 50.0
Mom 50.0
Weinstein Technical Phase
Neutral · Hold
Trend telemetry aligned with daily close.
RSI-14: N/A · SMA20: N/A · SMA50: N/A
ASPSZ
NASDAQ
Altisource Portfolio Solutions S.A. Cash Exercise Stakeholder Warrants
Services-Miscellaneous Business Services
Market Cap
N/A
TTM Revenue
N/A
Forward P/E
N/M
Beta / 30D Vol
0.76β · 196% Vol
Unified Composite Score
47.1 / 100
HOLD
Tech 40.0
Fund 42.0
Flow 50.0
Mom 70.0
Weinstein Technical Phase
Neutral · Hold
Mixed signals - no dominant trend phase, RSI 51
RSI-14: 50.5 · SMA20: $0.18 · SMA50: $0.17
6-Pillar Scorecard Institutional Category Breakdown (BDMDW 0 – 0 ASPSZ)
Columns: Metric · BDMDW · ASPSZ
1. Valuation Multiples
Tie
Forward P/E
N/M
N/M
Trailing P/E
N/M
N/M
PEG Ratio
N/M
N/M
EV / Revenue
N/M
N/M
2. Growth & Scale
Tie
Revenue Growth (YoY)
N/A
N/A
Earnings Growth (YoY)
N/A
N/A
TTM Revenue (USD)
N/A
N/A
Market Cap
N/A
N/A
3. Profitability & Quality
Tie
Gross Margin
N/A
N/A
Operating Margin
N/A
N/A
Net Profit Margin
N/A
N/A
Return on Equity (ROE)
N/A
N/A
4. Balance Sheet & Cash Flow
Tie
Cash Generation (TTM)
N/A
N/A
Cash Flow Margin
N/A
N/A
Net Cash / Leverage
N/A ROE
N/A ROE
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
Tie
Options Structure Phase
UNCLASSIFIED
UNCLASSIFIED
Current IV / %ile
N/A (N/A)
N/A (N/A)
Put/Call OI Skew
N/A
N/A
OBV Trend / Tech Phase
NEUTRAL · Neutral
NEUTRAL · Neutral
6. R&D & Supply-Chain Moat
Tie
OpEx & R&D Intensity
N/A
N/A
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Institutional Equity Operator
Services-Miscellaneous Business Services Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: BDMDW (1) vs ASPSZ (2)
Institutional Metric
BDMDW
ASPSZ
Criterion
Row Edge
Market Capitalization
Scale
N/A
N/A
Larger Scale
Tie
Trailing P/E Ratio
Valuation
N/M
N/M
Lower Multiple
Tie
Forward P/E Ratio
Valuation
N/M
N/M
Lower Multiple
Tie
Revenue Growth (YoY)
Growth
N/A
N/A
Higher Growth
Tie
Operating Margin (TTM)
Profitability
N/A
N/A
Higher Margin
Tie
Net Profit Margin
Profitability
N/A
N/A
Higher Margin
Tie
Return on Equity (ROE)
Capital Efficiency
N/A
N/A
Higher ROE
Tie
52-Week Range Position
Momentum
2% ($0–$0)
13% ($0–$1)
Stronger Trend
ASPSZ
Beta / 30D Volatility
Risk Regime
-0.19β · 641% Vol
0.76β · 196% Vol
Lower Realized Risk
ASPSZ
Unified Institutional Score
Composite Signal
48.8 / 100 (HOLD)
47.1 / 100 (HOLD)
Higher Composite
BDMDW
Trailing 12M Revenue (USD)
Operating Scale
N/A
N/A
FX-Normalized USD
Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A
N/A
Higher Margin
Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev
N/M PEG · N/M EV/Rev
Lower Multiple
Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE)
N/A (N/A ROE)
Higher Cash / Net Cash
Solvency
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M
3M
6M
1Y
1M Horizon
ASPSZ +22.21 pp
BDMDW:
-65.09%
·
ASPSZ:
-42.88%
3M Horizon
ASPSZ +46.95 pp
BDMDW:
-68.69%
·
ASPSZ:
-21.74%
6M Horizon
ASPSZ +5.37 pp
BDMDW:
-69.06%
·
ASPSZ:
-63.69%
1Y Horizon
ASPSZ +5.37 pp
BDMDW:
-69.06%
·
ASPSZ:
-63.69%
Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)
Split-Invariant USD Revenue & Operating Margin (%)
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BDMDW vs ASPSZ. Trailing 12-month operating profitability (BDMDW N/A vs ASPSZ N/A) and valuation multiples (BDMDW N/M vs ASPSZ N/M Forward P/E) are benchmarked directly in Pillar 4 below.
BDMDW ADR TTM Benchmark
FX-Normalized USD
TTM Revenue N/A
Gross Margin N/A
Op. Margin N/A
ROE / Fwd P/E N/A · N/M
ASPSZ ADR TTM Benchmark
FX-Normalized USD
TTM Revenue N/A
Gross Margin N/A
Op. Margin N/A
ROE / Fwd P/E N/A · N/M
BDMDW
UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
ASPSZ
UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
BDMDW Moat Profile
Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
ASPSZ Moat Profile
Cyclical / Execution-Driven Positioning
Services-Miscellaneous Business Services Operator
Competes within the Services-Miscellaneous Business Services value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
Investor FAQ BDMDW vs ASPSZ Key Questions & Quantitative Answers
Is BDMDW or ASPSZ a better stock to buy right now?
As of Nov 20, 2026, Baird Medical Investment Holdings Ltd Warrant (BDMDW) is the stronger overall head-to-head candidate over Altisource Portfolio Solutions S.A. Cash Exercise Stakeholder Warrants (ASPSZ) in the Tradestie Institutional Equity Comparison Engine, winning 1–2 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). BDMDW carries a Unified Composite Score of 48.8/100 (HOLD) at $0.02 (N/M Forward P/E, N/A operating margin), whereas ASPSZ carries 47.1/100 (HOLD) at $0.18 (N/M Forward P/E, N/A operating margin). Technically, BDMDW sits in a Neutral phase (RSI N/A, UNCLASSIFIED options structure) and ASPSZ sits in a Neutral phase (RSI 50.5, UNCLASSIFIED options structure).
Does BDMDW or ASPSZ have stronger revenue and earnings growth?
BDMDW and ASPSZ split Growth & Scale metrics: BDMDW posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with ASPSZ at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, BDMDW generates N/A in USD-normalized revenue versus N/A for ASPSZ. In operating R&D and SG&A reinvestment, BDMDW deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ASPSZ.
Is BDMDW or ASPSZ cheaper on valuation?
BDMDW and ASPSZ trade at balanced relative valuation multiples. BDMDW trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas ASPSZ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BDMDW (N/A ROE) versus ASPSZ (N/A ROE) capital efficiency.
How is options market volatility positioned on BDMDW vs ASPSZ?
In options market volatility and institutional positioning, BDMDW carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.19β · 641% Vol realized risk). By comparison, ASPSZ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.76β · 196% Vol realized risk).
Baird Medical Investment Holdings Ltd Warrant (BDMDW) Research Suite
Altisource Portfolio Solutions S.A. Cash Exercise Stakeholder Warrants (ASPSZ) Research Suite
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.